CoChat

Simvastatin prevents and ameliorates depressive behaviors via neuroinflammatory regulation in mice

Yu, Xu-Ben, Zhang, Hai-Na, Dai, Ying, Zhou, Zi-Ye, Xu, Ren-ai, Hu, Lu-Feng, Zhang, Chun-Hong, Xu, Hui-Qin, An, Yun-Qi, Tang, Cong-Rong, Lin, Guan-Yang · 2019 · Journal of Affective Disorders
Cited by 62

The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.

Abstract

BACKGROUND Statins play a beneficial role in the treatment of coronary artery disease and are widely prescribed to prevent hypercholesterolemia. Previous studies have demonstrated that statins also have anti-inflammatory and immunomodulatory properties, and these are being explored for potential benefits in depression. However, the role of statins in the treatment of depression has not been well examined. METHODS We investigated the effects of simvastatin on depressive behaviors and neuroinflammation in lipopolysaccharide (LPS) and chronic mild stress (CMS) induced depression model in mice. Sucrose preference test (SPT), forced swimming test (FST), novelty-suppressed feeding test (NSFT) were used to detect the depressive behaviors. The microglial activation was detected by immunohistochemistry analysis and the pro-inflammatory cytokines expressions including IL-1β, TNF-α and IL-6 were examined by Western blot analysis. RESULTS Our data indicated that oral administration of simvastatin at 20 mg/kg significantly prevented and ameliorated depressive behaviors reflected by better performance in the SPT, FST and NSFT. Moreover, simvastatin markedly prevented and ameliorated LPS and CMS-induced neuroinflammation, as shown by the suppressed activation of microglia in hippocampus and decreased hippocampal pro-inflammatory cytokines expressions including IL-1β, TNF-α, IL-6, which might be mediated via the inhibition of NF-κB pathway, as shown by the decreased nuclear NF-κB p65 expression. LIMITATIONS The interpretation of the evidence of a positive treatment effect of simvastatin on the depressive manifestations, multifaceted etiology of depression, and confirmation of this finding from animal models to humans is needed. CONCLUSION These results suggest that simvastatin has the potential to be employed as a therapy for depression associated with neuroinflammation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jad.2018.11.086

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 26 references

Cited by

See all 62

Metadata

Authors
Yu, X.-B., Zhang, H.-N., Dai, Y., Zhou, Z.-Y., Xu, R.-A., Hu, L.-F., Zhang, C.-H., Xu, H.-Q., An, Y.-Q., Tang, C.-R., & Lin, G.-Y.
Venue
Journal of Affective Disorders
Publisher
Elsevier BV
Published
2019-02
Volume
245
Pages
939-949
ISSN
0165-0327 (ISSN-L)
OpenAlex
W2901122766
Cited by
62
References
26
FWCI
1.70
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Simvastatin prevents and ameliorates depressive behaviors via neuroinflammatory regulation in mice. https://app.cochat.ai/papers/10.1016/j.jad.2018.11.086
The paper
Yu, X.-B., Zhang, H.-N., Dai, Y., Zhou, Z.-Y., Xu, R.-A., Hu, L.-F., Zhang, C.-H., Xu, H.-Q., An, Y.-Q., Tang, C.-R., & Lin, G.-Y. (2019). Simvastatin prevents and ameliorates depressive behaviors via neuroinflammatory regulation in mice. Journal of Affective Disorders. https://doi.org/10.1016/j.jad.2018.11.086

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.